Akorn (AKRX) Shares Drop After Accounting Error

Shares of leading drugmaker Akorn, Inc. (AKRX) plunged 14 percent in pre-market trading following the report of overstatement of revenue and downgrade. The company said it has discovered it overstated fiscal 2014 net revenue and pretax income by $20 to $35 million and that it will make additional accounting restatements for the final three quarters of […] View the full post at: Akorn (AKRX) Shares Drop After Accounting Error Related posts: Top Pre-Market Stock Upgrades/Downgrades April 26, 2010 China Accounting Shift Narrows Deficit Caterpillar Inc. Downgraded to “Neutral” at BofA